touchIN CONVERSATION for touchNEUROLOGY and touchONCOLOGY
Management of neurofibromatosis type 1 (NF1)–associated plexiform neurofibromas in adults requires individualized decisions that account for symptoms, function, resectability and patient goals. Listen to NF1 experts Prof. Allan Belzberg, a neurosurgeon, and Dr. Angela Hirbe, an oncologist, as they discuss targeted therapy, adverse-effect monitoring and management, and multidisciplinary approaches to assessing pain, function and quality of life to inform care decisions.
The experts
Prof. Allan Belzberg, Johns Hopkins Medicine, Baltimore, MD, USA
Dr. Angela Hirbe, Washington University, St Louis, MO, USA
This touchPODCAST is for HCPs globally, excluding the UK.
This activity is funded by an independent medical education grant from Alexion and SpringWorks Therapeutics, Inc.
This activity is jointly provided by USF Health and touchIME.
Podden och tillhörande omslagsbild på den här sidan tillhör
touchpodcast. Innehållet i podden är skapat av touchpodcast och inte av,
eller tillsammans med, Poddtoppen.